Use of antibiotics as a therapeutic approach to prevent AKI-to-CKD progression

肾脏疾病 急性肾损伤 肠道菌群 医学 抗生素 重症监护医学 失调 免疫学 内科学 生物 微生物学
作者
Yu Kurata,Masaomi Nangaku
出处
期刊:Kidney International [Elsevier BV]
卷期号:104 (3): 418-420 被引量:4
标识
DOI:10.1016/j.kint.2023.05.022
摘要

The microbiota plays important roles in the health and diseases of its host. Gharaie et al. demonstrated that antibiotic treatment, especially amoxicillin, facilitated the repair process from ischemic acute kidney injury despite postinjury administration through microbiota modulation. This commentary discusses the implications and limitations of the study's findings for utilizing gut microbiota modification with antibiotics as a novel therapeutic approach to prevent acute kidney injury–to–chronic kidney disease progression. The microbiota plays important roles in the health and diseases of its host. Gharaie et al. demonstrated that antibiotic treatment, especially amoxicillin, facilitated the repair process from ischemic acute kidney injury despite postinjury administration through microbiota modulation. This commentary discusses the implications and limitations of the study's findings for utilizing gut microbiota modification with antibiotics as a novel therapeutic approach to prevent acute kidney injury–to–chronic kidney disease progression. A growing body of evidence has unveiled microbiota's pivotal roles in its host's health and diseases. Microbiota interacts with the host's organs, including the kidneys, via metabolic and immune pathways. Recently, a novel theory, namely the "gut-kidney axis," has been proposed to explain the interaction between the gut microbiota and the kidney.1Inagi R. The gut-kidney connection in advanced chronic kidney disease.Kidney Res Clin Pract. 2015; 34: 191-193Crossref PubMed Scopus (6) Google Scholar The gut-kidney axis is bidirectional. Kidney diseases, including acute kidney injury (AKI) and chronic kidney disease (CKD), are associated with gut dysbiosis, which refers to an imbalance in gut microbiota. By contrast, gut dysbiosis contributes to the progression of AKI and CKD. An alteration in the gut microbiota occurs as early as 1 day after AKI.2Yang J. Kim C.J. Go Y.S. et al.Intestinal microbiota control acute kidney injury severity by immune modulation.Kidney Int. 2020; 98: 932-946Abstract Full Text Full Text PDF PubMed Scopus (55) Google Scholar This gut dysbiosis is associated with reduced levels of short-chain fatty acids (SCFAs), intestinal inflammation, and increased intestinal permeability, also known as leaky gut. Conversely, gut dysbiosis itself leads to the exacerbation of tissue damage in AKI, as demonstrated by fecal microbiota transplantation (FMT).2Yang J. Kim C.J. Go Y.S. et al.Intestinal microbiota control acute kidney injury severity by immune modulation.Kidney Int. 2020; 98: 932-946Abstract Full Text Full Text PDF PubMed Scopus (55) Google Scholar The uremic milieu also alters the composition of the gut microbiota. In patients with CKD, increased urea and uric acid levels lead to the expansion of microbial families possessing urease or uricase enzymes, which metabolize these excess substances. Conversely, uremic toxins, such as p-cresyl sulfate and indoxyl sulfate, are produced by the gut microbiota and associated with systemic inflammation, leading to further progression of CKD. Despite increasing recognition of the gut-kidney axis as a promising therapeutic target, there remains limited evidence regarding the specific alterations in the microbiota that are linked to the pathogenesis of kidney diseases, as well as which interventions may hold therapeutic promise. In their work, Gharaie et al. have provided new insight into the role of microbiota in the pathophysiology of AKI-to-CKD transition (Figure 1).3Gharaie S. Lee K. Newman-Rivera A.M. et al.Microbiome modulation after severe acute kidney injury accelerates functional recovery and decreases kidney fibrosis.Kidney Int. 2023; 104: 470-491Google Scholar They demonstrated the therapeutic potential of gut microbiome modification with antibiotic treatment, especially amoxicillin, in repair after ischemic AKI. Amoxicillin treatment following unilateral ischemic reperfusion injury (IRI) improved the recovery of glomerular filtration rate and mitigated kidney fibrosis. The protective effects of amoxicillin were not observed in germ-free mice. In addition, FMT from amoxicillin-treated mice to germ-free mice suppressed kidney medullary fibrosis after IRI. On the basis of these findings, the authors argued that the effects of amoxicillin were mediated by the altered gut microbiota. However, this inhibition of fibrosis with amoxicillin-modified microbiota was demonstrated in comparison with the control group that did not receive FMT, and no significant difference was identified compared with mice receiving FMT from normal mice that were not subjected to amoxicillin. Furthermore, there was no significant improvement in glomerular filtration rate recovery in mice with FMT from amoxicillin-treated mice compared with mice without FMT or mice with FMT from normal mice. Therefore, it is difficult to conclude from these results whether only the altered gut microbiota induced by amoxicillin treatment contributed to its renoprotective effects. Gut microbiome analysis using 16S rRNA sequencing revealed that α diversity, a term used to describe species diversity within an individual sample, increased 1 week after amoxicillin treatment compared with baseline and other antibiotic groups (metronidazole and a combination of antibiotics). The authors also investigated changes in microbial metabolites. SCFAs, produced by bacterial fermentation of dietary fiber, are known to have anti-inflammatory properties. To examine the possibility that SCFAs mediate the acceleration of the repair process, Gharaie et al. measured plasma levels of SCFAs. Only the levels of acetic acid were decreased after amoxicillin treatment, whereas the levels of other SCFAs were unchanged. Considering the prior report that acetate supplementation mitigated kidney injury following IRI,4Andrade-Oliveira V. Amano M.T. Correa-Costa M. et al.Gut bacteria products prevent AKI induced by ischemia-reperfusion.J Am Soc Nephrol. 2015; 26: 1877-1888Crossref PubMed Scopus (331) Google Scholar it is unlikely that the alteration in acetic acid levels contributed to the protective effect of amoxicillin treatment. Given that microbiota changes may affect immune responses, Gharaie et al. examined T-lymphocyte populations in the kidney. Amoxicillin treatment decreased interleukin-17+ CD4+ T cells and increased programmed cell death protein 1 (PD-1)+ CD8+ T cells in the kidneys. Interleukin-17 is a proinflammatory cytokine and is associated with tissue damage. PD-1 is an immune checkpoint molecule that is expressed in T cells. PD-1 signaling plays an important role in regulating T-cell effector functions. To explore whether CD4+ or CD8+ T cells were implicated in the renoprotective effects of amoxicillin, Gharaie et al. conducted experiments using CD4–/– or CD8–/– mice. Intriguingly, the acceleration of glomerular filtration rate recovery after IRI in response to amoxicillin administration was not seen in CD8–/– mice, but was seen in CD4–/– mice. Furthermore, amoxicillin treatment did not suppress kidney fibrosis following IRI in CD8–/– mice, indicating the potential involvement of PD-1+ CD8 T cells. The authors did not conduct histopathologic analysis to evaluate kidney fibrosis in CD4–/– mice and only presented data regarding the expression of fibrosis-related genes. Therefore, the provided data were insufficient to discuss the contribution of CD4 T cells in the development of fibrosis. PD-1 ligand 1 (PD-L1), a ligand of PD-1, is expressed in kidney tubular epithelial cells. An in vitro study revealed that the interaction of kidney tubular PD-L1 and PD-1 on CD8+ T cells dampened cytokine production.5Starke A. Lindenmeyer M.T. Segerer S. et al.Renal tubular PD-L1 (CD274) suppresses alloreactive human T-cell responses.Kidney Int. 2010; 78: 38-47Abstract Full Text Full Text PDF PubMed Scopus (60) Google Scholar In addition, a recent clinical trial has shown the efficacy of PD-1 receptor stimulation with a humanized monoclonal antibody in the treatment of rheumatoid arthritis, suggesting the role of PD-1 signaling in suppressing inflammation.6Tuttle J. Drescher E. Simon-Campos J.A. et al.A phase 2 trial of peresolimab for adults with rheumatoid arthritis.N Engl J Med. 2023; 388: 1853-1862Crossref PubMed Scopus (6) Google Scholar Hence, the increased count of PD-1+ CD8+ T cells in the kidney may underlie the protective effects of amoxicillin. This study provides an encouraging outlook for utilizing gut microbiota modification with antibiotics as a novel therapeutic approach to prevent AKI-to-CKD progression. There are no efficacious therapeutic interventions for established AKI, making prevention the main strategy. Therefore, the effectiveness of amoxicillin, despite being administered after onset AKI, offers a promising prospect for its clinical implementation. However, there are several limitations and challenges to the practical application of gut microbiome modification as a therapeutic option. First, the gut microbiome is dynamic and variable across and within individuals. The impact of antibiotics on the gut microbiome can be highly variable. In the study by Gharaie et al., the increase in α diversity after amoxicillin treatment was detected. Loss of microbial diversity is associated with various acute and chronic diseases.7Pickard J.M. Zeng M.Y. Caruso R. et al.Gut microbiota: role in pathogen colonization, immune responses, and inflammatory disease.Immunol Rev. 2017; 279: 70-89Crossref PubMed Scopus (795) Google Scholar Therefore, the enhanced α diversity by amoxicillin administration may have contributed to the observed beneficial effects on kidney tissue repair. However, another study demonstrated a reduction in α diversity of the gut microbiome following amoxicillin treatment,8Lekang K. Shekhar S. Berild D. et al.Effects of different amoxicillin treatment durations on microbiome diversity and composition in the gut.PLoS One. 2022; 17e0275737Crossref Scopus (6) Google Scholar which is in contrast to the findings of the study by Gharaie et al. This discordance may be attributed to the difference in the dosage of amoxicillin and/or environmental factors. Additional research is required to determine the specific types, dosages, and durations of antibiotics that can induce beneficial alterations in the gut microbiota. Second, there is concern about the generalizability. In their study, Gharaie et al. investigated the renoprotective potential of amoxicillin premedication. They identified that pretreatment with amoxicillin mitigated kidney injury in a model of bilateral IRI, but not in a cisplatin-induced AKI model. This suggests that the efficacy of amoxicillin on AKI is context dependent and may not be applicable to other types of kidney diseases. Third, antibiotic treatment has some undesirable consequences, including the selection of antibiotic-resistant strains and the possibility of inducing allergic reactions. A recent report showed that the administration of a probiotic Lactobacillus casei attenuated kidney damage after IRI.9Zhu H. Cao C. Wu Z. et al.The probiotic L. casei Zhang slows the progression of acute and chronic kidney disease.Cell Metab. 2021; 33: 1926-1942.e8Abstract Full Text Full Text PDF PubMed Scopus (66) Google Scholar This protective effect was also demonstrated in cisplatin-induced AKI and 5/6 nephrectomy models. Considering the potential adverse effects of antibiotics, probiotics may represent a safer and better-tolerated therapeutic option for the treatment of kidney diseases. In recent years, substantial efforts have been made to unravel the intricate interplay between the gut microbiome and the kidneys, leading to progressive advancements in our understanding of the underlying mechanisms involved. However, microbiome research still faces several challenges. Proving causality and identifying causal pathogens remain difficult because of the complex microbiome-host relationship. In addition, numerous confounders, such as diet and lifestyle, can modify the microbiome, and the lack of reproducibility across studies further complicates research in this field. Recent technological advancements, including omics-based strategies, will help us to elucidate the intricate complexity of the microbiome. Interdisciplinary approaches will be crucial to properly collect and interpret huge amounts of omics data and to fill the gap between basic science and clinical application. All the authors declared no competing interests. Microbiome modulation after severe acute kidney injury accelerates functional recovery and decreases kidney fibrosisKidney InternationalVol. 104Issue 3PreviewTargeting gut microbiota has shown promise to prevent experimental acute kidney injury (AKI). However, this has not been studied in relation to accelerating recovery and preventing fibrosis. Here, we found that modifying gut microbiota with an antibiotic administered after severe ischemic kidney injury in mice, particularly with amoxicillin, accelerated recovery. These indices of recovery included increased glomerular filtration rate, diminution of kidney fibrosis, and reduction of kidney profibrotic gene expression. Full-Text PDF
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小丑鱼儿发布了新的文献求助10
1秒前
XYN1发布了新的文献求助10
1秒前
4秒前
4秒前
LiuLiu完成签到,获得积分10
5秒前
樱桃小热巴完成签到 ,获得积分10
5秒前
6秒前
6秒前
不低头完成签到,获得积分10
6秒前
大鱼完成签到,获得积分10
7秒前
7秒前
XYN1完成签到,获得积分10
7秒前
MaYue发布了新的文献求助10
8秒前
8秒前
8秒前
闪闪发布了新的文献求助10
9秒前
尊敬依珊发布了新的文献求助10
10秒前
强强完成签到,获得积分10
11秒前
阿童木发布了新的文献求助10
13秒前
迷你的冰旋完成签到,获得积分10
13秒前
慕青应助卡琳采纳,获得10
14秒前
李健的小迷弟应助gunt采纳,获得30
14秒前
Lucas应助小陈同学采纳,获得10
17秒前
17秒前
油饼发布了新的文献求助10
18秒前
努力工作的人完成签到,获得积分10
20秒前
坦率的匪应助闪闪采纳,获得10
22秒前
22秒前
阿童木完成签到,获得积分10
22秒前
852应助灰灰子采纳,获得10
25秒前
ding应助美满的砖头采纳,获得10
26秒前
GooJohn完成签到,获得积分10
26秒前
26秒前
27秒前
小陈同学发布了新的文献求助10
28秒前
科研通AI5应助天玄一刀采纳,获得10
28秒前
飞天小女警完成签到,获得积分10
30秒前
梨里完成签到 ,获得积分10
30秒前
31秒前
长医德莱文完成签到,获得积分10
31秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3988868
求助须知:如何正确求助?哪些是违规求助? 3531255
关于积分的说明 11253071
捐赠科研通 3269858
什么是DOI,文献DOI怎么找? 1804822
邀请新用户注册赠送积分活动 881994
科研通“疑难数据库(出版商)”最低求助积分说明 809035